| Aug 6 |
Certara Non-GAAP EPS of $0.07 misses by $0.03, revenue of $93.3M misses by $2.71M
|
| Aug 6 |
Certara Reports Second Quarter 2024 Financial Results
|
| Aug 5 |
Certara Q2 2024 Earnings Preview
|
| Jul 29 |
Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue
|
| Jul 9 |
Certara to buy Chemaxon for drug discovery software portfolio
|
| Jul 9 |
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
|
| Jul 2 |
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
|
| Jun 17 |
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
|
